Jim Murray: Will governments support transparency for clinical trials?

Criticism of EU law is often aimed at an amorphous “Brussels,” but in many cases member states are the problem—as with the proposal to revise the Clinical Trials Directive. The proposal envisages a central EU portal and database of applications, assessments, safety reports, and other information about clinical trials. How comprehensive will that information be, […]

Read More…

djfhdkfdkjfhakdjfhkadsfhldksjfajdfkdajfhkdlsfhkdlsfhkdsfhskldfhdkfhdskl

Jim Murray: The EU, transparency, and access to clinical trial results

How is the EU involved in transparency and access to clinical trial results? Many readers will know this already, but perhaps not all. For obvious reasons, health professionals have tended to focus on the national and they might not all appreciate the strength of the “side-wind” blowing from the EU. The EU was formed on […]

Read More…

djfhdkfdkjfhakdjfhkadsfhldksjfajdfkdajfhkdlsfhkdlsfhkdsfhskldfhdkfhdskl